Download this Report to Learn More
Infectious diseases account for approximately 14 million deaths each year, disproportionately impacting low- and middle-income countries. Novotech’s latest report explores how the clinical trial landscape is evolving to meet these challenges and drive global health progress.
Key insights:
- Nearly 2,000 infectious disease trials initiated since 2020
- Asia-Pacific leads with 70% CAGR; North America follows with 52%
- Over 900 trials in viral infections including COVID-19, HIV/AIDS, hepatitis B, and RSV
- Emerging innovations: AI-driven discovery and decentralized trial models
- Regulatory harmonization and platform trials accelerating development timelines
- Antimicrobial resistance remains an urgent priority
Offered Free by: Novotech
See All Resources from: Novotech
